Clinical trial
Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors
NCT00096317 · Montefiore Medical Center, Other · Completed
Key facts
| NCT number | NCT00096317 |
|---|---|
| Title | Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors |
| Official title | The Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Ixabepilone In Patients With Advanced Cancer |
| Lead sponsor | Montefiore Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | ixabepilone, ketoconazole |
| Enrollment | 29 |
| Start date | Mar 1, 2003 |
| Primary completion | Dec 5, 2005 |
| Completion | Dec 5, 2005 |
| First posted | Nov 9, 2004 |
| Last update posted | Oct 31, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: